Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review.
作者信息
Carlini Sara V, Deligiannidis Kristina M
机构信息
Department of Psychiatry, Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA.
Zucker Hillside Hospital, 75-59 263rd St, Glen Oaks, NY 11004.
出版信息
J Clin Psychiatry. 2020 Feb 4;81(2):19ac13071. doi: 10.4088/JCP.19ac13071.
Abstract
摘要
相似文献
1
Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review.经前期烦躁障碍的循证治疗：简要综述
J Clin Psychiatry. 2020 Feb 4;81(2):19ac13071. doi: 10.4088/JCP.19ac13071.
2
Premenstrual Dysphoric Disorder.经前烦躁障碍。
Med Clin North Am. 2019 Jul;103(4):613-628. doi: 10.1016/j.mcna.2019.02.007.
3
Easing the burden of premenstrual dysphoric disorder.减轻经前烦躁障碍的负担。
J Fam Pract. 2013 Jan;62(1):E1-7.
4
Treatment of premenstrual dysphoric disorder with the GABA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.使用γ-氨基丁酸（GABA）受体调节性类固醇拮抗剂Sepranolone（UC1010）治疗经前烦躁障碍——一项随机对照试验
Psychoneuroendocrinology. 2017 Jun;80:46-55. doi: 10.1016/j.psyneuen.2017.02.031. Epub 2017 Mar 1.
5
Premenstrual disorders.经前期障碍。
Am J Obstet Gynecol. 2018 Jan;218(1):68-74. doi: 10.1016/j.ajog.2017.05.045. Epub 2017 May 29.
6
Premenstrual Dysphoric Disorder.经前烦躁障碍
Psychiatr Clin North Am. 2017 Jun;40(2):201-216. doi: 10.1016/j.psc.2017.01.002. Epub 2017 Mar 1.
7
Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline.一例服用舍曲林的经前烦躁障碍患者的低血糖发作
Indian J Pharmacol. 2015 Sep-Oct;47(5):567-8. doi: 10.4103/0253-7613.165193.
8
Premenstrual Syndrome and Premenstrual Dysphoric Disorder.经前期综合征和经前期烦躁障碍
Am Fam Physician. 2016 Aug 1;94(3):236-40.
9
Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.青少年的经前综合征和经前烦躁障碍
Curr Probl Pediatr Adolesc Health Care. 2022 May;52(5):101187. doi: 10.1016/j.cppeds.2022.101187. Epub 2022 May 6.
10
The pharmacologic management of premenstrual dysphoric disorder.经前烦躁障碍的药物治疗
Expert Opin Pharmacother. 2008 Feb;9(3):429-45. doi: 10.1517/14656566.9.3.429.
引用本文的文献
1
Mechanism of intermittent dosing of fluoxetine in premenstrual dysphoric disorder.氟西汀间歇给药治疗经前烦躁障碍的机制
Arch Womens Ment Health. 2025 Jul 10. doi: 10.1007/s00737-025-01610-0.
2
Premenstrual Dysphoric Disorder: A Cross-Sectional Study on Prevalence and Awareness Among Medical Students.经前烦躁障碍：一项关于医学生患病率及认知情况的横断面研究
Cureus. 2025 Mar 20;17(3):e80917. doi: 10.7759/cureus.80917. eCollection 2025 Mar.
3
Lithium in the Treatment of Premenstrual Dysphoric Disorder: A Case Report.锂盐治疗经前烦躁障碍：一例报告
Turk Psikiyatri Derg. 2024 Sep 19;35(4):329-32. doi: 10.5080/u27350.
4
Understanding the Interplay Between Premenstrual Dysphoric Disorder (PMDD) and Female Sexual Dysfunction (FSD).了解经前烦躁障碍（PMDD）与女性性功能障碍（FSD）之间的相互作用。
Cureus. 2024 Jun 20;16(6):e62788. doi: 10.7759/cureus.62788. eCollection 2024 Jun.
5
Determinants of premenstrual dysphoric disorder and associated factors among regular undergraduate students at Hawassa University Southern, Ethiopia, 2023: institution-based cross-sectional study.2023 年，埃塞俄比亚 Hawassa 大学南部地区普通本科生经前期心绪不良障碍的决定因素及其相关因素：基于机构的横断面研究。
BMC Public Health. 2024 May 23;24(1):1390. doi: 10.1186/s12889-024-18798-y.
6
(S)-S-adenosylmethionine in the treatment of pre-menstrual disorders in adult women: A protocol for an open-label pilot study.（S）-S-腺苷甲硫氨酸治疗成年女性经前疾病：一项开放标签试点研究方案。
Contemp Clin Trials Commun. 2024 Mar 30;39:101297. doi: 10.1016/j.conctc.2024.101297. eCollection 2024 Jun.
7
Global burden and trends in female premenstrual syndrome study during 1990-2019.全球 1990-2019 年经前期综合征女性患者负担及变化趋势研究。
Arch Womens Ment Health. 2024 Jun;27(3):369-382. doi: 10.1007/s00737-024-01426-4. Epub 2024 Jan 27.
8
Diagnosis and Management of Perimenstrual Cycloid Motility Psychosis.围经期循环性运动性精神病的诊断与管理
Harv Rev Psychiatry. 2024;32(1):33-39. doi: 10.1097/HRP.0000000000000386.
9
Diagnostic validity of premenstrual dysphoric disorder: revisited.经前烦躁障碍的诊断效度：再探讨
Front Glob Womens Health. 2023 Nov 27;4:1181583. doi: 10.3389/fgwh.2023.1181583. eCollection 2023.
10
Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal.口服避孕药使用者短期停药期间的心理健康症状。
JAMA Netw Open. 2023 Sep 5;6(9):e2335957. doi: 10.1001/jamanetworkopen.2023.35957.
本文引用的文献
1
Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.经口服避孕药连续与间歇性给药治疗经前期烦躁障碍：一项三臂随机对照试验的结果。
Depress Anxiety. 2017 Oct;34(10):908-917. doi: 10.1002/da.22673. Epub 2017 Jul 17.
2
Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.卵巢抑制后的经前烦躁障碍症状：由卵巢甾体激素水平变化引发而非持续稳定水平。
Am J Psychiatry. 2017 Oct 1;174(10):980-989. doi: 10.1176/appi.ajp.2017.16101113. Epub 2017 Apr 21.
3
Treatment of premenstrual dysphoric disorder with the GABA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.使用γ-氨基丁酸（GABA）受体调节性类固醇拮抗剂Sepranolone（UC1010）治疗经前烦躁障碍——一项随机对照试验
Psychoneuroendocrinology. 2017 Jun;80:46-55. doi: 10.1016/j.psyneuen.2017.02.031. Epub 2017 Mar 1.
4
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.舍曲林症状发作时给药治疗经前烦躁障碍：一项随机临床试验。
JAMA Psychiatry. 2015 Oct;72(10):1037-44. doi: 10.1001/jamapsychiatry.2015.1472.
5
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.5α-还原酶抑制可预防黄体期血浆别孕烯醇酮水平升高，并减轻经前烦躁障碍女性的症状。
Neuropsychopharmacology. 2016 Mar;41(4):1093-102. doi: 10.1038/npp.2015.246. Epub 2013 Aug 14.
6
Selective serotonin reuptake inhibitors for premenstrual syndrome.用于经前综合征的选择性5-羟色胺再摄取抑制剂
Cochrane Database Syst Rev. 2013 Jun 7;2013(6):CD001396. doi: 10.1002/14651858.CD001396.pub3.
7
ISPMD consensus on the management of premenstrual disorders.国际经前障碍共识会议关于经前障碍管理的共识声明。
Arch Womens Ment Health. 2013 Aug;16(4):279-91. doi: 10.1007/s00737-013-0346-y. Epub 2013 Apr 27.
8
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder.连续口服左炔诺孕酮/炔雌醇治疗经前烦躁障碍。
Contraception. 2012 Jan;85(1):19-27. doi: 10.1016/j.contraception.2011.05.008. Epub 2011 Jul 13.
9
Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen.周期性服用含有 20 微克炔雌醇和 3 毫克屈螺酮的复方口服避孕药，以 24/4 给药方案，可改善经前期烦躁障碍症状群。
Contraception. 2011 Jul;84(1):81-6. doi: 10.1016/j.contraception.2010.10.010. Epub 2010 Dec 17.
10
Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.屈螺酮炔雌醇片（每片含炔雌醇 20μg 及屈螺酮 3mg），每日 1 片，用于治疗经前期烦躁障碍（PMDD）女性的功能障碍。
Int J Gynaecol Obstet. 2011 May;113(2):103-7. doi: 10.1016/j.ijgo.2010.10.029. Epub 2011 Feb 19.
Zotero 插件